A systematic safety pipeline for selection of T-cell receptors to enter clinical use

Zsófia Földvári(Oslo University Hospital), Johanna Olweus(Oslo University Hospital)
npj Vaccines
August 22, 2023
10.1038/s41541-023-00713-y
Cited by 20

Related Papers

Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
|Science|2016|448
Non-viral vectors for chimeric antigen receptor immunotherapy
|Nature Reviews Methods Primers|2024|12
Beyond Spike: Identification of nine highly prevalent SARS-CoV-2-specific CD8 T-cell epitopes in a large Norwegian cohort
|bioRxiv (Cold Spring Harbor Laboratory)|2021|2